{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:22:43Z","timestamp":1791591763519,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T00:00:00Z","timestamp":1286409600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10096-010-1077-x","type":"journal-article","created":{"date-parts":[[2010,10,6]],"date-time":"2010-10-06T21:12:49Z","timestamp":1286399569000},"page":"251-257","source":"Crossref","is-referenced-by-count":58,"title":["Medical-grade honey enriched with antimicrobial peptides has enhanced activity against antibiotic-resistant pathogens"],"prefix":"10.1007","volume":"30","author":[{"given":"P. H. S.","family":"Kwakman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. P.","family":"Ruyter-Spira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Creemers-Molenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P. F. G.","family":"Helsper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. M. J. E.","family":"Vandenbroucke-Grauls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A. J.","family":"Zaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"te Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,7]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"crossref","DOI":"10.1128\/9781555817886","volume-title":"Antibiotics: actions, origins, resistance","author":"C Walsh","year":"2003","unstructured":"Walsh C (2003) Antibiotics: actions, origins, resistance. American Society for Microbiology (ASM) Press, Washington"},{"key":"1077_CR2","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1038\/nm1145","volume":"10","author":"SB Levy","year":"2004","unstructured":"Levy SB, Marshall B (2004) Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10:S122\u2013S129","journal-title":"Nat Med"},{"key":"1077_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325:1089\u20131093","journal-title":"Science"},{"key":"1077_CR4","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1046\/j.1365-2672.2002.01761.x","volume":"93","author":"RA Cooper","year":"2002","unstructured":"Cooper RA, Molan PC, Harding KG (2002) The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J Appl Microbiol 93:857\u2013863","journal-title":"J. Appl Microbiol"},{"key":"1077_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/bjs.1800750718","volume":"75","author":"SEE Efem","year":"1988","unstructured":"Efem SEE (1988) Clinical observations on the wound healing properties of honey. Br J Surg 75:679\u2013681","journal-title":"Br J Surg"},{"key":"1077_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S1473-3099(03)00794-1","volume":"3","author":"D Bonn","year":"2003","unstructured":"Bonn D (2003) Sweet solution to superbug infections? Lancet Infect Dis 3:608","journal-title":"Lancet Infect Dis"},{"key":"1077_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/S1473-3099(03)00524-3","volume":"3","author":"B Dixon","year":"2003","unstructured":"Dixon B (2003) Bacteria can\u2019t resist honey. Lancet Infect Dis 3:116","journal-title":"Lancet Infect Dis"},{"key":"1077_CR8","first-page":"295","volume":"29","author":"PE Lusby","year":"2002","unstructured":"Lusby PE, Coombes A, Wilkinson JM (2002) Honey: a potent agent for wound healing? J Wound Ostomy Continence Nurs 29:295\u2013300","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"1077_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/ecam\/nem175","volume":"6","author":"A Simon","year":"2009","unstructured":"Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P (2009) Medical honey for wound care\u2014still the \u2018latest resort\u2019? Evid Based Complement Alternat Med 6:165\u2013173","journal-title":"Evid Based Complement Alternat Med"},{"key":"1077_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/0005772X.1992.11099118","volume":"73","author":"PC Molan","year":"1992","unstructured":"Molan PC (1992) The antibacterial activity of honey. 2. Variation in the potency of the antibacterial activity. Bee World 73:59\u201376","journal-title":"Bee World"},{"key":"1077_CR11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.2042-7158.1991.tb03186.x","volume":"43","author":"KL Allen","year":"1991","unstructured":"Allen KL, Molan PC, Reid GM (1991) A survey of the antibacterial activity of some New Zealand honeys. J Pharm Pharmacol 43:817\u2013822","journal-title":"J Pharm Pharmacol"},{"key":"1077_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.carres.2007.12.011","volume":"343","author":"CJ Adams","year":"2008","unstructured":"Adams CJ, Boult CH, Deadman BJ, Farr JM, Grainger MN, Manley-Harris M, Snow MJ (2008) Isolation by HPLC and characterisation of the bioactive fraction of New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 343:651\u2013659","journal-title":"Carbohydr Res"},{"key":"1077_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/mnfr.200700282","volume":"52","author":"E Mavric","year":"2008","unstructured":"Mavric E, Wittmann S, Barth G, Henle T (2008) Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 52:483\u2013489","journal-title":"Mol Nutr Food Res"},{"key":"1077_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/BF01921753","volume":"51","author":"T Postmes","year":"1995","unstructured":"Postmes T, van den Bogaard AE, Hazen M (1995) The sterilization of honey with cobalt 60 gamma radiation: a study of honey spiked with spores of Clostridium botulinum and Bacillus subtilis. Experientia 51:986\u2013989","journal-title":"Experientia"},{"key":"1077_CR15","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1086\/587892","volume":"46","author":"PHS Kwakman","year":"2008","unstructured":"Kwakman PHS, Van den Akker JPC, G\u00fc\u00e7l\u00fc A, Aslami H, Binnekade JM, de Boer L, Boszhard L, Paulus F, Middelhoek P, te Velde AA, Vandenbroucke-Grauls CMJE, Schultz MJ, Zaat SAJ (2008) Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization. Clin Infect Dis 46:1677\u20131682","journal-title":"Clin Infect Dis"},{"key":"1077_CR16","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1096\/fj.09-150789","volume":"24","author":"PHS Kwakman","year":"2010","unstructured":"Kwakman PHS, te Velde AA, de Boer L, Speijer D, Vandenbroucke-Grauls CMJE, Zaat SAJ (2010) How honey kills bacteria. FASEB J 24:2576\u20132582","journal-title":"FASEB J"},{"key":"1077_CR17","doi-asserted-by":"publisher","first-page":"8347","DOI":"10.1021\/bi000946l","volume":"39","author":"HW Huang","year":"2000","unstructured":"Huang HW (2000) Action of antimicrobial peptides: two-state model. Biochemistry 39:8347\u20138352","journal-title":"Biochemistry"},{"key":"1077_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/bip.10260","volume":"66","author":"Y Shai","year":"2002","unstructured":"Shai Y (2002) Mode of action of membrane active antimicrobial peptides. Biopolymers 66:236\u2013248","journal-title":"Biopolymers"},{"key":"1077_CR19","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1021\/bi0004549","volume":"39","author":"S Kobayashi","year":"2000","unstructured":"Kobayashi S, Takeshima K, Park CB, Kim SC, Matsuzaki K (2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39:8648\u20138654","journal-title":"Biochemistry"},{"key":"1077_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0005-2736(99)00198-4","volume":"1462","author":"RM Epand","year":"1999","unstructured":"Epand RM, Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462:11\u201328","journal-title":"Biochim Biophys Acta"},{"key":"1077_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0005-2736(99)00197-2","volume":"1462","author":"K Matsuzaki","year":"1999","unstructured":"Matsuzaki K (1999) Why and how are peptide\u2013lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1462:1\u201310","journal-title":"Biochim Biophys Acta"},{"key":"1077_CR22","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2174\/1381612023395501","volume":"8","author":"DA Devine","year":"2002","unstructured":"Devine DA, Hancock RE (2002) Cationic peptides: distribution and mechanisms of resistance. Curr Pharm Des 8:703\u2013714","journal-title":"Curr Pharm Des"},{"key":"1077_CR23","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.1128\/JCM.43.9.4862-4864.2005","volume":"43","author":"N Al Naiemi","year":"2005","unstructured":"Al Naiemi N, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, Bart A, Vandenbroucke-Grauls CM, de Jong MD (2005) Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol 43:4862\u20134864","journal-title":"J Clin Microbiol"},{"key":"1077_CR24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/00218839.1963.11100066","volume":"2","author":"JW White Jr","year":"1963","unstructured":"White JW Jr, Subers MH (1963) Studies on honey inhibine. 2. A chemical assay. J Apic Res 2:93\u2013100","journal-title":"J Apic Res"},{"key":"1077_CR25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1128\/IAI.63.2.663-671.1995","volume":"63","author":"J Dankert","year":"1995","unstructured":"Dankert J, van der Werff J, Zaat SAJ, Joldersma W, Klein D, Hess J (1995) Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect Immun 63:663\u2013671","journal-title":"Infect Immun"},{"key":"1077_CR26","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1182\/blood.V90.7.2796","volume":"90","author":"O S\u00f8rensen","year":"1997","unstructured":"S\u00f8rensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N (1997) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90:2796\u20132803","journal-title":"Blood"},{"key":"1077_CR27","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1128\/IAI.67.5.2561-2566.1999","volume":"67","author":"M Frohm Nilsson","year":"1999","unstructured":"Frohm Nilsson M, Sandstedt B, S\u00f8rensen O, Weber G, Borregaard N, St\u00e5hle-B\u00e4ckdahl M (1999) The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 67:2561\u20132566","journal-title":"Infect Immun"},{"key":"1077_CR28","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1128\/AAC.00575-06","volume":"50","author":"PHS Kwakman","year":"2006","unstructured":"Kwakman PHS, te Velde AA, Vandenbroucke-Grauls CMJE, van Deventer SJH, Zaat SAJ (2006) Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2. Antimicrob Agents Chemother 50:3977\u20133983","journal-title":"Antimicrob Agents Chemother"},{"key":"1077_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/10755530360623383","volume":"9","author":"LM Bang","year":"2003","unstructured":"Bang LM, Buntting C, Molan P (2003) The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing. J Altern Complement Med 9:267\u2013273","journal-title":"J Altern Complement Med"},{"key":"1077_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00006534-198503000-00016","volume":"75","author":"W Lineaweaver","year":"1985","unstructured":"Lineaweaver W, Mcmorris S, Soucy D, Howard R (1985) Cellular and bacterial toxicities of topical antimicrobials. Plast Reconstr Surg 75:394\u2013396","journal-title":"Plast Reconstr Surg"},{"key":"1077_CR31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00129334-200509000-00011","volume":"18","author":"JR Wilson","year":"2005","unstructured":"Wilson JR, Mills JG, Prather ID, Dimitrijevich SD (2005) A toxicity index of skin and wound cleansers used on in vitro fibroblasts and keratinocytes. Adv Skin Wound Care 18:373\u2013378","journal-title":"Adv Skin Wound Care"},{"key":"1077_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/00139709-200423010-00006","volume":"23","author":"BE Watt","year":"2004","unstructured":"Watt BE, Proudfoot AT, Vale JA (2004) Hydrogen peroxide poisoning. Toxicol Rev 23:51\u201357","journal-title":"Toxicol Rev"},{"key":"1077_CR33","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1016\/S0021-9258(19)38596-5","volume":"265","author":"S Fujiwara","year":"1990","unstructured":"Fujiwara S, Imai J, Fujiwara M, Yaeshima T, Kawashima T, Kobayashi K (1990) A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J Biol Chem 265:11333\u201311337","journal-title":"J Biol Chem"},{"key":"1077_CR34","doi-asserted-by":"crossref","first-page":"28569","DOI":"10.1016\/S0021-9258(19)61943-5","volume":"269","author":"K Casteels-Josson","year":"1994","unstructured":"Casteels-Josson K, Zhang W, Capaci T, Casteels P, Tempst P (1994) Acute transcriptional response of the honeybee peptide-antibiotics gene repertoire and required post-translational conversion of the precursor structures. J Biol Chem 269:28569\u201328575","journal-title":"J Biol Chem"},{"key":"1077_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cbi.2007.11.009","volume":"171","author":"MP Kalapos","year":"2008","unstructured":"Kalapos MP (2008) The tandem of free radicals and methylglyoxal. Chem Biol Interact 171:251\u2013271","journal-title":"Chem Biol Interact"},{"key":"1077_CR36","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414:813\u2013820","journal-title":"Nature"},{"key":"1077_CR37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0014-4800(03)00035-2","volume":"75","author":"AW Stitt","year":"2003","unstructured":"Stitt AW (2003) The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 75:95\u2013108","journal-title":"Exp Mol Pathol"},{"key":"1077_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-5793(95)01050-O","volume":"374","author":"M Zanetti","year":"1995","unstructured":"Zanetti M, Gennaro R, Romeo D (1995) Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 374:1\u20135","journal-title":"FEBS Lett"},{"key":"1077_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/00062752-200201000-00004","volume":"9","author":"RI Lehrer","year":"2002","unstructured":"Lehrer RI, Ganz T (2002) Cathelicidins: a family of endogenous antimicrobial peptides. Curr Opin Hematol 9:18\u201322","journal-title":"Curr Opin Hematol"},{"key":"1077_CR40","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.jdermsci.2005.07.009","volume":"40","author":"F Niyonsaba","year":"2005","unstructured":"Niyonsaba F, Ogawa H (2005) Protective roles of the skin against infection: Implication of naturally occurring human antimicrobial agents beta-defensins, cathelicidin LL-37 and lysozyme. J Dermatol Sci 40:157\u2013168","journal-title":"J Dermatol Sci"},{"key":"1077_CR41","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/S0140-6736(02)11201-3","volume":"360","author":"K P\u00fctsep","year":"2002","unstructured":"P\u00fctsep K, Carlsson G, Boman HG, Andersson M (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360:1144\u20131149","journal-title":"Lancet"},{"key":"1077_CR42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/MMBR.60.3.539-574.1996","volume":"60","author":"JR Govan","year":"1996","unstructured":"Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60:539\u2013574","journal-title":"Microbiol Rev"},{"key":"1077_CR43","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1021\/bi00459a004","volume":"29","author":"GM Clore","year":"1990","unstructured":"Clore GM, Appella E, Yamada M, Matsushima K, Gronenborn AM (1990) Three-dimensional structure of interleukin 8 in solution. Biochemistry 29:1689\u20131696","journal-title":"Biochemistry"},{"key":"1077_CR44","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.42.9.2206","volume":"42","author":"J Turner","year":"1998","unstructured":"Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother 42:2206\u20132214","journal-title":"Antimicrob Agents Chemother"},{"key":"1077_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1472-765x.2000.00756.x","volume":"31","author":"RA Cooper","year":"2000","unstructured":"Cooper RA, Wigley P, Burton NF (2000) Susceptibility of multiresistant strains of Burkholderia cepacia to honey. Lett Appl Microbiol 31:20\u201324","journal-title":"Lett Appl Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1077-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-010-1077-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1077-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-010-1077-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T11:30:33Z","timestamp":1636630233000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-010-1077-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,7]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s10096-010-1077-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,7]]}}}